Frequency of Treatment Failure of UTIs in Children With Congenital Urinary Tract Anomalies

Catherine S Forster1, Alexis C Wood2, Stephanie Davis-Rodriguez3

  • 1University of Pittsburgh, Pittsburgh, Pennsylvania.

Hospital Pediatrics
|February 20, 2024
PubMed

Insights

Children with congenital anomalies of the kidney and urinary tract and neurogenic bladder (CAKUT/NGB) had a 6.0% urinary tract infection (UTI) treatment failure rate. Antibiotic duration did not impact UTI treatment failure in these children.

Area of Science:

  • Pediatric Nephrology
  • Pediatric Urology
  • Infectious Diseases

Background:

  • Children with congenital anomalies of the kidney and urinary tract and neurogenic bladder (CAKUT/NGB) face higher risks of urinary tract infection (UTI) treatment failure.
  • Limited literature exists on treatment strategies and outcomes for UTIs in this vulnerable pediatric population.

Purpose of the Study:

  • To determine the treatment failure rate for UTIs in children with CAKUT/NGB.
  • To compare antibiotic durations between children with and without UTI treatment failure.

Main Methods:

  • A multicenter retrospective cohort study included 482 children (0-17 years) diagnosed with UTI between 2017-2018.
  • Treatment failure was defined as a subsequent UTI-related ED visit or hospitalization within 30 days.
  • Descriptive statistics and univariate analyses were employed.

Main Results:

  • 6.0% of UTI encounters in children with CAKUT/NGB resulted in treatment failure.
  • No significant difference was observed in the mean duration of intravenous or total antibiotic courses between treatment failure and success groups.
  • A higher rate of bacteremia was noted in children experiencing treatment failure (P = .04).

Conclusions:

  • Urinary tract infections in children with CAKUT/NGB demonstrate a 6.0% treatment failure rate.
  • Antibiotic duration was not found to be associated with treatment failure in this cohort.
  • Further research is warranted to investigate the role of bacteremia in modifying UTI treatment failure risk in these patients.
Abstract